Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression

Completed

• Conditions: Hepatic Fibrogenesis; Hepatitis C

• Registration Number: NCT00205075
• Lead Sponsor: University of Wisconsin, Madison

Brief Summary

The purpose of this study is to determine the effect of moderate alcohol intake on liver disease caused by HCV in terms of speed of progression as compared to those not drinking alcohol.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-08
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-20
• Primary Completion: 2008-06
• Study Completion: 2008-06
• Status Verified: 2015-12
• Last Update Submitted: 2015-12-07
• Last Update Posted: 2015-12-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 47

Inclusion Criteria

• Outpatient with HCV who is not receiving or planning treatment but is receiving standard of care monitoring every 3 months and is either abstinent from alcohol or drinking only moderately

Exclusion Criteria

• HIV co-infection
• Treated within the past 6 months
• History (hx) of other liver disease
• Alcohol use greater than 30 g/day or history of binge drinking in the last year
• Decompensated liver disease

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

University of Wisconsin; 🇺🇸 Madison, Wisconsin, United States